Vontobel Holding Ltd. 4 D Molecular Therapeutics, Inc. Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 03, 2024	BUY	$9.76 - $21.25 $604,934 - $1.32 Million	61,981 Added 76.97%	142,510 $2.89 Million
Q4 2023 Jan 29, 2024	BUY	$9.76 - $21.25 $1.39 Million - $3.03 Million	142,510 New	142,510 $2.89 Million
Q1 2023 Jun 03, 2024	BUY	$15.45 - $23.19 $1.24 Million - $1.87 Million	80,529 New	80,529 $1.38 Million
Q1 2023 Apr 12, 2023	BUY	$15.45 - $23.19 $412,406 - $619,010	26,693 Added 49.58%	80,529 $1.38 Million
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $368,776 - $1.37 Million	53,836 New	53,836 $1.2 Million

150

56.3M

55.6K

167K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $337M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.